There are a variety of legal claims that can be brought in relation to Standard Essential Patents (SEP), such as patent infringement, breach of contract, and antitrust. Adding an additional layer of complexity is the assortment of remedies potentially available for such claims, including damages, injunctive relief, specific performance, various declarations, and anti-suit injunctions.

Join us on Thursday, December 11, at 12 PM ET, for a discussion on some of the SEP-related claims that have been brought in the United States, the relief that is typically granted, and how such relief compares to other jurisdictions and non-SEP situations.

Moderated by Curtis Dodd, CLO and CIPO of Harfang IP, with an introduction to the topic by Gene Quinn, founder of IPWatchdog, our panel, which includes Kevin Burgess, a principal in McKool Smith’s Marshall office, and Kristen Osenga, Associate Dean for Academic Affairs, Julie & John Nowak Faculty Research Scholar and Professor of Law at the University of Richmond School of Law, will explore the views of different United States’ courts and government agencies on this increasingly complex topic.